Quarterly Result30 Jan 2026, 03:00 pm
Epigral Ltd's Q3FY26 Revenue Stands at ¥ 603 Crore, Despite Temporary Marginal Pressures
AI Summary
Epigral Limited, a leading integrated chemical manufacturer in India, announced its financial results for the quarter ended December 31, 2025. The company posted a revenue of ¥ 603 Crore for Q3FY26, a decrease from ¥ 649 Crore in Q3FY25. The Profit After Tax (PAT) stood at ¥ 39 Crore compared to ¥ 104 Crore in Q3FY25. The company's plant utilization stood at 78%, similar to the previous quarter. The EBITDA margin dropped to 17% due to lower realizations and increased raw material costs. The company is optimistic about the improving market scenario and anticipates positive outcomes from Q4FY26. Epigral's capacity expansion projects are progressing smoothly and are expected to drive growth from FY27 onwards.
Key Highlights
- Q3FY26 Revenue stood at ¥ 603 Crore
- Plant utilization at 78%
- EBITDA margin at 17% due to drop in realizations and increase in cost of raw materials
- PAT at ¥ 39 Crore
- Capacity expansion projects progressing smoothly